Watchtower Advisors, LP
Net seller this quarter
$180M
11
-$21.4M
97.8%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 ASML | $62.2M | 34.63% | 0.01% | Not reported | Q3 2025 |
 OHI | $25.8M | 14.37% | 0.18% | Not reported | Q4 2025 |
 CVS | $18.9M | 10.50% | 0.01% | Not reported | Q1 2022 |
 MU | $13.9M | 7.71% | 0.00% | -47.9% | Q1 2026 |
 PATK | $13.5M | 7.50% | 0.47% | Not reported | Q2 2025 |
 TXT | $11.5M | 6.41% | 0.07% | New | Q2 2026 |
 SRE | $10.5M | 5.86% | 0.02% | +218.2% | Q1 2026 |
 IBP | $7.42M | 4.13% | 0.12% | Not reported | Q2 2025 |
 NOK | $6.64M | 3.70% | 0.01% | New | Q2 2026 |
 ELAN | $5.46M | 3.04% | 0.04% | +50.0% | Q1 2026 |
 AMD | $3.87M | 2.16% | 0.00% | -83.3% | Q2 2025 |
| Q1 2026 | |||||
| ASML | $41.3M | 29.29% | 0.01% | Not reported | Q3 2025 |
| OHI | $23.7M | 16.82% | 0.18% | +59.6% | Q4 2025 |
| PATK | $16.7M | 11.82% | 0.45% | Not reported | Q2 2025 |
| CVS | $13.1M | 9.29% | 0.01% | -48.9% | Q1 2022 |
 SGI | $10.3M | 7.33% | 0.07% | +37.9% | Q4 2025 |
| IBP | $8.56M | 6.07% | 0.12% | Not reported | Q2 2025 |
| AMD | $8.14M | 5.77% | 0.00% | -33.3% | Q2 2025 |
| MU | $7.79M | 5.52% | 0.00% | New | Q1 2026 |
| ELAN | $3.54M | 2.51% | 0.03% | New | Q1 2026 |
 AVGO | $3.48M | 2.47% | 0.00% | -62.6% | Q3 2023 |
| SRE | $3.47M | 2.46% | 0.01% | New | Q1 2026 |
 APH | $932K | 0.66% | 0.00% | -92.6% | Q4 2023 |
| Q4 2025 | |||||
| ASML | $33.4M | 20.20% | 0.01% | +54.5% | Q3 2025 |
| CVS | $28.3M | 17.11% | 0.03% | Not reported | Q1 2022 |
| PATK | $16.3M | 9.82% | 0.45% | Not reported | Q2 2025 |
| OHI | $15M | 9.08% | 0.11% | New | Q4 2025 |
| APH | $13.5M | 8.16% | 0.01% | -23.1% | Q4 2023 |
| AMD | $12.8M | 7.76% | 0.00% | Not reported | Q2 2025 |
 RCL | $11.2M | 6.74% | 0.01% | -27.6% | Q3 2024 |
| AVGO | $10.4M | 6.27% | 0.00% | -11.7% | Q3 2023 |
| SGI | $9.06M | 5.47% | 0.05% | New | Q4 2025 |
| IBP | $8.37M | 5.06% | 0.12% | Not reported | Q2 2025 |
 AZO | $7.18M | 4.34% | 0.01% | Not reported | Q2 2023 |
| Q3 2025 | |||||
| CVS | $26.9M | 12.56% | 0.03% | +37.3% | Q1 2022 |
| ASML | $18.6M | 8.67% | 0.01% | New | Q3 2025 |
| RCL | $17.9M | 8.34% | 0.02% | Not reported | Q3 2024 |
 CLH | $17.7M | 8.25% | 0.14% | New | Q3 2025 |
| APH | $16.1M | 7.51% | 0.01% | -6.3% | Q4 2023 |
| PATK | $15.5M | 7.24% | 0.45% | +50.0% | Q2 2025 |
 AXS | $14.4M | 6.70% | 0.19% | -42.3% | Q2 2024 |
 AMRZ | $13.8M | 6.44% | 0.05% | New | Q3 2025 |
| AVGO | $11.2M | 5.23% | 0.00% | -12.8% | Q3 2023 |
 APPF | $11M | 5.14% | Not reported | -34.7% | Q2 2025 |
| AMD | $9.71M | 4.53% | 0.00% | +14.6% | Q2 2025 |
 BLDR | $9.09M | 4.24% | 0.07% | +28.3% | Q2 2025 |
| AZO | $9.09M | 4.24% | 0.01% | Not reported | Q2 2023 |
 LII | $7.97M | 3.72% | 0.04% | Not reported | Q2 2023 |
| IBP | $7.96M | 3.71% | 0.12% | +30.5% | Q2 2025 |
| VRNA | $7.47M | 3.48% | 0.01% | Not reported | Q4 2024 |